atpas
activ
studi
plasma
membran
rich
fraction
isol
control
polioviru
infect
la
cell
compar
membran
potenti
amino
acid
uptak
parallel
cultur
intact
cell
na
k
pase
activ
membran
infect
hela
cell
increas
rel
control
maximum
minut
post
infect
decreas
rnin
similar
slighter
chang
observ
membran
potenti
depend
tetraphenylphosphonium
pp
uptak
indic
correl
membran
porenti
intact
cell
measur
plasma
membran
na
k
pase
approxim
h
post
infect
observ
decreas
uptak
amino
acid
methionin
leucin
infect
cell
rel
control
result
suggest
declin
amino
acid
upt
ake
mediat
virusinduc
chang
na
k
atpas
activ
membran
potenti
mpi
f
biochem
abt
virolog
martinsri
sequenc
homolog
differ
strain
fmdv
picoma
virus
marquardt
restrict
enzym
gener
subgenom
fragment
clone
cdna
prepar
rna
strain
fmdv
compar
quantit
sequenc
complementar
radioact
rna
strain
cobb
rna
mengo
polio
viru
hybrid
experi
use
southern
techniqu
nucleic
acid
sequenc
neighbour
includ
end
viral
genom
demonstr
ofo
homolog
fmdv
contrast
sequenc
code
capsid
protein
vpl
remark
heterolog
less
fmdv
sequenc
code
nonstructur
protein
show
homolog
thu
highli
conserv
code
sequenc
detect
fmdv
techniqu
hybrid
could
detect
specif
dna
polio
rna
weak
hybrid
observ
mengo
rna
area
includ
end
part
gene
precursor
protein
schaefer
zibirr
r
kabu
p
kohn
jutta
koch
g
na
k
atpas
activ
studi
plasma
membran
rich
fraction
isol
control
polioviru
infect
la
cell
compar
membran
potenti
amino
acid
uptak
parallel
cultur
intact
cell
na
k
pase
activ
membran
infect
hela
cell
increas
rel
control
maximum
minut
post
infect
decreas
rnin
similar
slighter
chang
observ
membran
potenti
depend
tetraphenylphosphonium
pp
uptak
indic
correl
membran
porenti
intact
cell
measur
plasma
membran
na
k
pase
approxim
h
post
infect
observ
decreas
uptak
amino
acid
methionin
leucin
infect
cell
rel
control
result
suggest
declin
amino
acid
upt
ake
mediat
virusinduc
chang
na
k
atpas
activ
membran
potenti
mpi
f
biochem
abt
virolog
sequenc
homolog
differ
strain
fmdv
picoma
virus
marquardt
restrict
enzym
gener
subgenom
fragment
clone
cdna
prepar
rna
strain
fmdv
compar
quantit
sequenc
complementar
radioact
rna
strain
cobb
rna
mengo
polio
viru
hybrid
experi
use
southern
techniqu
nucleic
acid
sequenc
neighbour
includ
end
viral
genom
demonstr
ofo
homolog
fmdv
contrast
sequenc
code
capsid
protein
vpl
remark
heterolog
less
fmdv
sequenc
code
nonstructur
protein
show
homolog
thu
highli
conserv
code
sequenc
detect
fmdv
techniqu
hybrid
could
detect
specif
dna
polio
rna
weak
hybrid
observ
mengo
rna
area
includ
end
part
gene
precursor
protein
abr
molekularbiologi
physiolchern
inst
grindelalle
hamburg
modif
polioviru
capsid
protein
scharli
claudia
koch
g
polioviru
type
strain
mohoney
contain
protein
kinas
activ
highli
purifi
two
cycl
csci
gradient
centrifug
polioviru
prepar
abl
transfer
yphosphorylgroup
atp
acid
precipit
materi
reaction
product
anal
yzed
sd
page
structur
protein
polio
phoshoryl
label
incorpor
minor
capsid
protein
vpo
lesser
extend
hepat
viru
hav
isol
directli
human
stool
diploid
human
fibroplasr
viral
antigen
express
day
incub
infect
cultur
contrast
hav
first
adapt
growth
human
hepatocellular
carcinoma
cell
caus
antigen
express
fibroplast
cultur
alreadi
day
infect
passag
time
first
appear
antigen
infect
fibroblast
decreas
day
passag
seri
e
cultur
inocul
viru
recov
directli
human
stool
adapt
human
hepatoma
cell
antigen
predominantli
cellassoci
shown
immunofluoresc
locat
exclus
cytoplasm
biophys
properti
hav
particl
extract
infect
cell
compar
describ
hav
extract
human
stool
find
import
prepar
larg
amount
hav
vaccin
product
max
von
pettenkoferinst
u
inst
f
biochemi
univ
miinchen
clone
hepat
viru
genom
helm
k
von
der
winnack
e
l
deinhardt
f
subgenom
fragment
genom
rna
hepat
viru
hav
clone
via
edna
pst
site
pbr
restrict
enzym
pattern
analysi
hybrid
clone
hav
dna
select
fragment
ha
v
rna
determin
major
part
clone
hav
dna
fragment
locat
end
genom
clone
distribut
entir
genom
identifi
subtyp
specif
site
hbvrestrict
map
map
align
eco
ri
site
subtyp
ay
reveal
one
subtyp
specif
site
xbai
bp
h
ine
bp
bam
hi
bp
situ
ate
outsid
sgene
employ
rhi
system
subti
pe
three
hbvona
sequenc
ha
publish
far
could
determin
thereupon
first
triplet
hbv
ad
dna
sequenc
sgene
could
com
pare
pub
lish
data
nucleotid
exchang
triplet
cau
se
aminoacid
aa
exchang
bu
cha
nge
triplet
caus
exchang
thu
subtyp
ay
aa
thr
aa
thr
wh
ile
subtyp
ad
aa
ser
aa
pro
exchang
may
produc
differ
conf
ormat
th
e
peptid
dept
ed
mic
robio
l
univ
gottingen
character
hepat
b
viru
hbv
associ
proteinkinas
gerlich
w
h
purifi
hbvcore
prepar
shown
contain
pr
ot
eink
inas
phosphori
late
major
core
protein
albin
robinson
studi
found
th
th
enzym
copurifi
light
heavi
subfract
coreparticl
enzym
high
affin
atp
transfer
approx
one
ph
osphat
e
per
particl
within
minut
introd
uce
vitro
remov
coreparticl
digest
alkalin
ph
osph
ase
lysi
core
so
cleav
rhe
protein
suggest
th
th
e
enzym
ph
osphat
acceptor
site
locat
pa
rticl
acid
hydrolysi
incor
porat
p
comigr
ph
osph
oserin
phosphor
hreonin
pho
pho
tryosin
ax
von
petrenk
oferinst
univ
miin
chen
phosphokinas
activ
associ
hepat
b
viru
hbv
core
helm
k
von
der
roggendorf
siegert
w
prepar
ation
core
antigen
posit
hbcag
fraction
obta
ine
hbv
posit
hu
man
liver
tissu
associ
ph
osphokinas
wh
ich
copurifi
hbcag
cscl
densityand
sucros
veloc
grad
ient
centrifug
acceptor
protein
kina
se
hbcag
protein
casein
exogen
acceptor
also
phospho
rylat
minor
extend
ph
osphoryl
amino
acid
serin
threonin
tyrosi
ne
frequent
case
tumor
viru
specif
prot
ein
kinas
dept
med
microbiol
univ
gott
ingen
effect
glycosidas
protein
hepat
b
surfac
antigen
hbsag
stibb
w
gerlich
w
h
protein
composit
purifi
hbsag
stud
i
stain
silver
additio
n
hbsag
two
furt
protein
found
consist
prepar
differ
blood
donor
glycoprotein
natur
gp
gp
shown
increas
electrophoret
mobil
treatment
endoglycosidas
h
neuraminidas
immun
precipit
antihb
ripabuff
confirm
specif
glycoprotein
chang
appar
mol
weight
treatment
neuraminidas
larger
data
suggest
gp
multipli
glycosyl
protein
nglycosid
link
carbohydr
side
chain
mix
type
inst
f
virologi
univ
hb
antigen
screen
done
blood
sampl
pregnant
women
blood
sampl
found
hb
antigen
posit
women
asymptom
carrier
woman
suffer
chronic
hepat
children
born
examin
cord
blood
show
hb
antigen
sampl
venou
blood
sampl
taken
thereupon
demonstr
hb
antigen
two
sampl
hb
antigen
neg
children
treat
hbig
followup
examin
treat
children
show
sign
infect
one
child
born
hb
e
antigen
posit
mother
alreadi
infect
time
birth
anoth
child
born
anti
hb
e
posit
mother
becam
hb
antigen
posit
age
month
unfortun
child
treat
hbig
time
birth
willer
h
ponnath
h
sipo
moller
r
sera
pregnant
women
live
hannov
area
investig
presenc
hbsag
healthi
hbsag
carrier
found
among
women
german
origin
among
foreignborn
women
southern
european
noneuropean
countri
hbsag
carrier
german
women
foreignborn
women
recogn
hbeagposit
risk
perinat
transmiss
hepat
b
viru
infant
hbeagposit
mother
suggest
hbeagneg
mother
thu
hannov
area
infant
born
german
mother
infant
born
ro
foreign
mother
becom
hbsag
carrier
due
perinat
hepat
b
virusinfect
max
von
pettenkof
insr
univ
munich
radioimmunoassay
antihbc
igm
use
higher
concentr
dilut
serum
mgml
hbcag
mgml
compar
elisa
test
din
microb
iol
onl
hbsag
posit
blood
or
posit
elisa
correl
ation
total
anti
hbc
titer
could
found
fraction
ation
serum
discrep
result
positi
result
found
elisa
igg
fraction
collabor
stu
dy
atorf
et
al
present
also
lisbo
n
easl
show
ed
fold
reduct
hepat
b
titer
mean
iplluv
treatm
nt
effect
cold
steril
procedur
regard
reduc
viru
infect
considera
bli
greater
pasteur
h
dc
shikata
et
al
sho
wed
fold
reduct
hep
atiti
b
viru
infect
also
found
factor
ix
conc
ntrate
stab
iliz
serum
der
ive
pool
coldsteril
hu
man
plasma
transmit
neither
hepat
b
hepatit
na
nonb
chimpa
nzee
max
von
pettenk
oferinsr
miinchen
comparison
differ
evalu
system
determin
viral
antibodi
igg
igm
class
enzymeimmunoassay
r
g
g
endorf
zachov
r
zoulek
g
nd
deinharot
f
enzymeimmunoassay
use
demonstr
antibodi
igg
igm
class
viral
antigen
reveal
high
sensit
onset
acut
viral
infect
igm
antibodi
demonstr
serum
dilut
due
th
high
sensit
determin
ation
antibodi
tite
rs
accur
reproduc
titer
end
point
determ
ine
dilut
sera
give
sampleo
neg
control
equal
greater
dete
rminat
antibodi
con
centr
ation
evalu
method
propos
correl
measur
sera
one
dilut
ion
step
refer
serum
defin
arbitrarili
contain
anti
bodi
unit
use
elisa
detect
antibodi
adenoviru
signific
increas
antibod
unit
acut
phase
sera
convalesc
pha
se
sera
observ
low
day
da
varia
tion
seen
test
car
rie
differ
day
elisa
design
detect
anti
bodi
tickborn
e
enceph
viru
th
e
igm
class
day
day
variatio
n
use
antibodi
unit
significantli
lower
th
use
pin
ratio
inst
f
virolog
ie
jusrusliebi
gun
iv
gieben
maxplanckinsr
f
olekular
genet
ik
looo
berlin
structur
function
core
protein
alphavirus
boeg
ulrik
witt
man
nliebold
brigitt
com
plete
primari
struc
ture
core
protein
sindbi
semliki
forest
viru
establish
pr
ote
inchem
method
protein
contain
cluster
basic
amino
acid
prolin
th
e
ntermin
part
suggest
th
function
bind
nucl
ic
acid
ctermi
nal
pa
rt
ext
ensiv
iden
tical
sequenc
region
pr
ob
abl
p
rovid
recognit
site
pr
oteinprotein
interact
protein
contain
within
highl
conserv
portion
sequenc
glyaspsergli
wh
ich
typic
serin
proteas
like
relat
cata
lytic
function
core
prot
ein
proteas
wh
en
cleav
peptid
chai
n
nascent
protein
precursor
experiment
studi
use
peptid
contain
certai
n
sequenc
region
help
elucid
relationship
struc
ture
function
ac
ute
persist
infectio
n
rab
i
viru
h
ep
fluri
establish
th
e
cn
sderiv
cell
ng
cell
possess
specif
membran
recept
or
mani
hormon
es
neurotran
smitter
includ
opiat
receptor
case
found
increas
th
e
dissoci
constant
kn
agonist
hine
estim
scatcha
rd
plot
ana
lysi
h
owe
ver
case
th
ere
chang
th
e
nu
mb
er
op
iat
e
receptor
per
cell
compa
red
uninfect
cell
studi
complet
previou
publish
observ
impai
rme
nt
f
receptor
func
tion
rabi
viru
inf
cted
cell
kosch
el
k
halb
ach
j
gen
virol
insr
f
virolog
u
immunobi
olo
gie
univ
wiirzburg
effect
measl
sspe
antiserum
viral
surfac
protein
hormon
receptor
activ
persist
infect
cell
barrett
p
n
koschel
k
report
th
measl
anti
erum
ca
n
modul
express
certain
viru
prot
ein
acu
teli
measl
infect
cell
exam
ine
th
e
effect
measl
sspe
antiserum
exp
ressio
n
vira
l
surfac
protein
infect
cell
shown
redu
ction
ount
viral
antigen
present
memb
rane
cell
follow
incuba
tion
sspe
antiserum
demonstr
immunofluoresc
rad
ioimmunoassay
howev
loss
antigen
effect
memb
rane
receptor
link
camp
synthesi
discuss
respect
effect
viru
antigen
insert
cell
membran
specialis
membran
bound
function
analyz
effect
phosphoryl
dephosphoryl
structur
dna
bind
antigen
nondenatur
poregradi
gel
purifi
protein
migrat
appar
size
dalton
vitro
phosphoryl
protein
kinas
associ
purifi
protein
result
shift
protein
size
dalton
form
contain
phosphat
incorpor
aggreg
complet
revers
treatment
phosphoryl
antigen
alkalin
phosphatas
partial
tryptic
digest
indic
phosphoryl
site
nvrermin
part
protein
respons
observ
aggreg
show
n
protein
blot
onto
nitrocellulos
filter
predominantli
dalton
form
bound
dna
howev
onl
fraction
vitro
phosphoryl
protein
bind
dna
suggest
aggreg
alon
suffici
dna
bind
ing
subclass
larg
antigen
separ
zone
veloc
sediment
three
major
form
sedirn
shown
differ
biolog
biochem
subclass
test
specif
bind
restrict
fragment
dna
use
immunoprecipit
assay
three
form
antigen
bound
specif
restrict
fragment
contain
origin
replic
howev
form
bound
origin
fragment
per
unit
antigen
form
form
bound
equal
well
origin
dna
presenc
absenc
excess
cellul
ar
dna
wherea
bind
form
reduc
presenc
cellular
dna
form
antigen
cell
bound
much
less
origin
dna
infect
cell
fan
nowak
burger
j
wart
scrape
sever
small
skin
region
epidermodysplasia
verruciformi
patient
test
papilomavirusspecif
sequenc
mean
dna
uncleav
wart
dna
contain
uniform
full
length
hpv
genom
cleavag
bam
hi
reveal
six
differ
pattern
surpris
heterogen
even
within
small
biopsi
least
two
viru
type
show
limit
crosshybrid
hpv
one
close
resembl
hpv
bam
hi
fragment
eco
ri
fragment
hind
ii
fragment
c
viru
perfectli
hybrid
hpv
b
anneal
partial
f
g
show
detect
hybrid
dna
four
subtyp
partial
character
map
dna
hpv
viru
detect
probe
center
carcinoma
patient
forehead
dna
persist
extrachromosom
genom
equival
per
cell
inst
f
virologi
zentrum
hygien
univ
hermannherderstr
freiburg
gene
express
papillomavirus
hamster
tumor
frees
u
k
schult
p
pfister
h
bpv
includ
fibrosarcoma
hamster
tumor
contain
larg
amount
complet
viru
genom
persist
extrachromosom
evid
capsid
protein
synthesi
viru
particl
product
use
system
studi
earli
viral
gene
express
rna
tumor
contain
singl
virusspecif
rna
nucleotid
shown
polyadenyl
affin
chromatographi
polyuesepharos
transcrib
dna
region
bpv
map
within
two
hpa
ii
fragment
next
bam
hi
cleavag
site
within
x
bam
hiieco
ri
fragment
crosshybrid
studi
low
stringenc
reveal
sequenc
relationship
hpv
hpv
dna
transcrib
region
bpv
inst
genet
univ
cologn
adenoviru
type
cell
system
permiss
analysi
viral
dna
tumor
cell
starzinskipowitz
schulz
doerfler
w
interact
virus
eucaryot
cell
studi
genet
well
defin
system
like
mous
system
investig
whether
ad
dna
abl
replic
primari
mous
kidney
cell
mous
cell
line
shown
southern
blot
experi
dna
abl
replic
cell
w
herea
prima
ry
mous
kidn
cell
balbc
x
fl
origin
viral
dna
repl
icat
moreov
subcutan
inject
mice
variou
genet
origin
ab
mice
inject
one
rumor
emerg
balblc
mous
almost
month
inject
restrict
pattern
anal
ysi
rumor
dna
indic
abou
copi
dn
integr
coval
bound
cellular
dna
th
e
techniqu
avail
delet
rearrang
viral
dna
could
found
site
jun
ction
betw
een
viral
cellular
dna
clone
sequenc
inst
genet
univ
co
logn
viruscel
dna
recombin
human
cell
lytic
infect
neumann
r
weyer
u
doerfler
w
ampl
evid
notion
viruscel
dna
recombin
form
human
cell
product
infect
adenoviru
type
high
molecular
weight
form
detect
h
postinfect
gener
high
frequenc
limit
set
rather
specif
recombin
produc
neumann
doerfler
j
virol
suggest
th
recomb
inat
exhibit
cert
specif
succeed
molecularli
clone
dna
frag
ment
excis
high
mole
cular
weight
dn
hum
cell
th
e
restri
ction
endonucleas
ecori
agtw
ab
acharon
clon
ed
frag
ment
sequenc
ho
molog
viral
cellular
na
th
result
provid
proof
fo
r
occurr
viruscel
dna
recombi
na
nt
inst
genet
univ
cologn
unmethyl
dna
sequenc
promot
region
integr
adenoviru
gene
correl
gene
express
kruczek
doerfler
w
invers
correl
establish
level
dn
met
hylat
site
specif
segment
integr
adenoviru
dna
extent
wh
ich
se
segment
express
sutt
er
doerfler
pna
similar
correlatio
ns
report
viral
nonvir
system
recent
result
vitro
experi
prov
ide
direct
evid
notion
th
dna
methyl
specif
site
led
gene
inactiv
vardimon
et
al
pna
press
present
stud
detai
led
methyl
map
h
paiilm
spi
site
express
earli
silent
late
gene
dn
determin
three
ansform
hamster
cell
line
earli
region
int
grate
dna
unmethyl
particular
promot
er
region
unrnethyl
ar
hpall
site
three
line
investig
late
regio
ns
includ
promot
er
site
complet
meth
ylate
gahlmann
r
deur
r
stabel
winterhoff
u
doerfler
w
site
junction
viral
cellular
dna
sequenc
investig
two
problem
site
insert
viral
dna
specif
type
recombinatori
event
occur
viral
dna
integr
studi
junction
site
hamster
line
he
hamster
tumor
line
claci
viruscel
dna
junction
clone
dna
bacteriophag
jb
appropri
restrict
fragment
sequenc
maxamgilbert
techniqu
direct
sequenc
ident
appar
viral
cellular
junction
sequenc
delet
termini
viral
genom
seen
involv
clacl
nucleotid
peculiar
patch
type
homolog
cellular
viral
sequenc
adjac
site
junction
also
remot
area
observ
patch
may
import
function
integr
recombin
buttner
w
veresmalnar
block
j
first
step
understand
relationship
structur
function
adenoviru
type
dna
bind
protein
dbp
begun
determin
primari
structur
dbp
gene
isol
character
tupaia
adenoviru
tav
report
order
construct
genet
map
tav
genom
use
temperaturesensit
mutant
ts
tav
necessari
varieti
ts
mutant
av
gener
treatment
av
virion
x
pfu
hydroxylamin
isol
preliminari
character
six
mutant
replic
tupaia
embryon
kidney
cell
dc
replic
well
character
mutant
carri
use
complement
test
host
rang
studi
dna
anal
ysi
use
differ
restrict
enzym
accord
complement
analysi
four
group
determin
group
ts
group
ii
ts
group
iii
ts
group
iv
ts
host
rage
studi
reveal
ts
also
properti
host
rang
mutant
mutant
replic
tupaia
bab
fibroblast
contrast
wildtyp
viru
genom
analysi
mutant
reveal
mutat
region
locat
map
unit
addit
ts
mutant
delet
kb
kb
map
unit
detect
interact
viral
substructur
serum
serumcompon
resp
final
stage
cours
mani
viral
infect
complet
viru
particl
well
viral
substructur
enter
intercellular
space
e
g
hbsag
hbcag
hepat
b
viru
infect
present
studi
deal
interact
potenti
infecti
adenoviru
core
dnaspecif
antibodi
immunoglobulin
solut
absorb
dnaantigen
core
prepar
sarcosyl
treatment
purifi
adenoviru
typ
electron
microscopi
immunocomplex
could
demonstr
compos
sever
individu
core
unit
buoyant
densiti
centrifug
metrizamid
gradient
drastic
rise
densiti
core
could
shown
immunoglobulin
solut
absorb
nativ
well
denatur
dna
far
complex
could
assess
cell
line
design
sever
cell
clone
establish
skin
tumour
sporad
leukosi
form
cell
prove
free
bovin
leukemia
blv
bovin
virus
indirect
immunofluoresc
macroschizont
theileria
speci
seen
cytoplasm
cell
origin
blvantibodi
neg
anim
carri
femal
karyotyp
morpholog
aberr
evid
possibl
cell
origin
cell
obtain
inocul
x
loa
cell
nude
mice
transplant
tumour
develop
incorporarion
electron
microscopi
product
retroviru
particl
cultur
cell
detect
simultan
detect
test
highmolecular
weight
rna
comigr
felv
rna
demonstr
antigen
genet
relationship
th
e
skin
tumour
viru
isol
blv
major
mammalian
retrov
irus
found
support
stiftung
volkswagenwerk
abt
f
pathologi
gesellschafl
f
strahlenu
umweldorschung
neuherberg
insectpathogen
baculovirus
studi
activ
endogen
ctype
retrovirus
mammalian
cell
cultur
schmidt
j
erfl
v
activ
endogen
ctype
retrovirus
baculovirus
studi
vitro
cell
cultur
system
four
mammalian
speci
mous
rat
monkey
man
cell
treat
baculovirus
larva
insect
cell
cultur
baculovirusdna
crype
retrovirusactiv
chemic
chemic
insecticid
alon
combin
activ
retrovir
genom
test
determin
revers
transcriptas
activiri
concentr
cell
cultur
supernat
demonstr
intracellular
localis
retroviru
structur
protein
appli
indirect
immunoperoxydas
techniqu
ctype
retrovirus
activ
mous
cell
halogen
pyrimidin
analogu
iododeoxyuridin
baculovirustr
cell
cultur
ctype
retroviru
activ
detect
simultan
treatment
cell
baculovirus
chemic
potenti
effect
could
detect
virion
baculovirus
mammalian
cell
cultur
show
unalt
morpholog
upon
reisol
infect
homolog
insect
cell
cultur
lower
approxim
one
log
influenc
upon
growth
morpholog
cell
could
observ
gene
product
replicationdefect
oncornavirus
high
molecular
weight
protein
compris
gag
relat
one
gene
product
probabl
cleav
proteas
gene
lack
vitro
howev
gagspecif
peptid
sequenc
cleav
upon
addit
purifi
viral
pi
proteas
case
replicationdefect
transform
avian
sarcoma
viru
prc
ii
cleav
nongag
part
ryrosinephosphorylar
kinas
activ
similar
describ
rsv
srcgene
product
src
process
gp
precursor
viral
glycoprotein
rou
sarcoma
viru
bosch
v
schwarz
r
ziemiecki
frii
r
r
viral
glycoprotein
rou
sarcoma
viru
synthes
via
precursor
polyprotein
precursor
alreadi
glycosyl
contain
polypeptid
studi
natur
site
process
matur
disulfidelink
vgp
could
show
addit
proteolyt
cleavag
process
involv
convers
highmannos
oligosaccharid
found
complex
sialid
oligosaccharid
found
vgp
experi
pertain
site
process
indic
process
occur
extracellularli
propos
other
iklemenz
diggelmann
j
virol
determin
small
amount
matur
vgp
found
infect
cell
lysat
local
chiefli
within
cell
cell
surfac
favour
view
glycosyl
proteolyt
cleavag
occur
concomitantli
smooth
membran
within
cell
subsequ
export
viru
rapid
paulehrlichinst
frankfurt
lnst
f
virologi
univ
giefen
protein
molecular
weight
found
phosphoryl
h
onset
cell
transform
rou
sarcoma
viru
rsv
assum
physiolog
target
kinas
sinc
apart
phosphoryl
transform
cell
phosphoryl
vitro
kinas
tyrosin
use
differ
chromatograph
procedur
chromatographi
deaesephacel
poli
sepharos
blue
sepharos
hydroxylapatit
isoelectr
focus
gel
filtrat
protein
could
separ
cytosol
malic
dehydrogenas
activ
cm
dh
antiserum
protein
inhibit
cmdh
transformationspecif
protein
vmyc
acut
avian
leukemia
viru
donner
p
greiserwilk
iren
moell
karin
avian
acut
leukemia
virus
transform
cell
viruscod
oncogen
case
rnyelocytornatosi
viru
transform
fibroblast
well
bone
marrow
cell
vitro
oncogen
fuse
viral
structur
compon
fusion
protein
vrnyc
character
use
monoclon
antibodi
transform
quail
fibroblast
produc
viru
analyz
b
immunofluoresc
nuclear
fluoresc
observ
detect
normal
cell
virusproduc
cell
monoclon
antibodi
use
purifi
vmyc
protein
immunoaffin
chromatographi
purif
achiev
singlestep
purif
fold
elut
protein
precipit
antisera
character
biolog
properti
med
poliklinik
univ
miinchen
abr
f
pathologi
gsf
neuherberg
biochem
character
antigen
human
leukem
sera
crossreact
sisv
leib
c
schetter
h
erfl
v
hehlmann
r
antigen
crossreact
core
protein
baboon
endogen
viru
baev
andor
simian
sarcoma
associ
viru
sisv
isol
human
leukem
sera
immunoaffin
chromatographi
antigen
appar
molecular
weight
sdspolyacrylamid
gel
electrophoresi
peptid
map
perform
antigen
two
differ
leukem
sera
show
two
antigen
ident
peptid
analys
sisv
baev
simultan
map
protein
mix
human
antigen
show
major
peptid
sisv
major
peptid
baev
ident
mobil
peptid
human
antigen
human
serum
albumin
transferrin
fibrinogen
igg
igm
share
clearli
less
peptid
ident
mobil
human
antigen
isoglycoprotein
purifi
fmulv
particl
propag
evelin
cell
solubil
freez
thaw
ion
exchang
chromatographi
phosphocellulos
prepar
sdspage
prior
amino
acid
nh
amino
acid
sequenc
analysi
purifi
glycoprotein
subject
high
perform
liquid
chromatographi
hplc
remov
contamin
nh
amino
acid
sequenc
residu
found
differ
posit
highli
relat
fmulv
show
homolog
lack
potenti
glycosyl
site
sequon
posit
fmulv
rmulv
et
al
laborato
ry
breast
cer
normal
breast
tissu
benign
breast
lesion
carcin
om
south
german
patient
test
crossrea
ctivit
w
ith
test
done
indirect
immunoperoxidas
stain
paraffinsect
use
antis
ra
prov
ide
dr
spiegelman
n
specif
posit
reaction
wa
control
preabsorpt
purifi
breast
cancer
benign
breast
lesion
gave
posit
reaction
wherea
normal
bre
ast
tissu
carcinoma
neg
test
might
addit
use
diagnost
l
earl
detect
micrometastas
assign
metastas
unknown
pr
imari
tumor
doubt
case
breast
cancer
possibl
serv
add
ition
criterion
classif
mastopath
i
virus
wer
e
found
patient
nearli
ill
caus
mumpsand
enterovirus
viru
se
found
less
case
mumpsmeningitid
ascertain
constantli
year
increas
incid
nce
meningitid
caus
echoviru
type
wa
seen
seaso
na
l
dep
endenc
occurr
mump
viru
meningitid
meningitid
caus
ent
erovirus
found
mor
e
often
autumn
male
patient
fell
ill
twice
oft
n
femal
patient
mumpsmeningitid
rarel
found
first
year
life
contra
enteroviru
meningitid
could
dete
cted
first
year
caus
men
ingitid
age
viru
meningitid
among
adult
rarel
found
suspect
number
peripher
facial
pares
pfp
consid
idiopath
might
fact
viral
aetiolog
patient
cologn
univers
ent
clinic
socal
idiopath
pfp
examin
aspect
viral
aetiolog
case
condit
virolog
investig
optim
pair
sera
first
serum
within
first
week
onset
diseas
case
viral
infect
could
proven
varicella
zoster
viru
herp
simplex
viru
coxsacki
b
vzv
case
minim
zoster
lesion
observ
facial
thorac
among
oth
er
patient
late
sera
viral
infect
could
proven
conclus
mean
alert
clinic
virolog
examinat
ion
consider
fract
ion
idiopath
pfp
could
associ
viru
infect
neonat
screen
deliveri
time
discharg
rotaviru
infect
daili
faecal
specimen
examin
enzymelink
immunosorb
assay
elisa
subgroup
posit
specimen
also
test
neg
stain
electromicro
scopic
method
babi
found
excret
rotaviru
asymptomat
infect
show
mild
gastrointestin
symptom
one
except
virus
detect
babi
less
h
old
excret
viru
second
day
life
day
neonat
posit
rotaviru
excret
persist
day
accord
studi
babi
excret
roraviru
day
great
number
stool
first
da
test
elisa
found
nonspecif
activ
absenc
rotavir
antigen
theref
ore
stool
specimen
examin
electron
microscopi
singl
radial
hemolysi
test
srhtest
hemolysisingel
test
suitabl
techniqu
detect
rubella
influenza
antibodi
larg
number
sera
stud
look
effect
att
achment
viral
antigen
erythrocyt
differ
coupl
reagent
chrom
ic
chlorid
cyanogen
chlorid
glutaraldehyd
tetraazot
dianisid
ine
tod
use
sensit
erythrocyt
rubella
srhtest
improv
regard
sensit
test
seen
moreov
possibl
detect
igm
specif
antibodi
differ
kind
attach
srhtest
influenza
srhtest
allanto
fluid
egg
infect
h
viru
possibl
increas
sensit
tod
chromic
chlorid
potassium
period
tweeneth
treat
hemagglutinin
use
sensit
tod
chromic
chlorid
period
hemolyt
zone
detect
univkinderkiinik
mathildenstr
freiburg
rnaelectropherotyp
human
rotavirus
pastor
rotavirus
contain
doublestrand
ribonucl
acid
genom
consist
segment
easili
extract
crude
stool
suspens
method
rodger
et
al
j
clin
microbi
rota
antigen
posit
sampl
contain
suffici
rna
produc
satisfi
pattern
sdsacrylamideelectrophoresi
demonstr
six
electropherotyp
differ
rel
mobil
segment
diarrhea
produc
strain
least
two
differ
electropherotyp
found
everi
outbreak
rotaviru
gastroenter
find
good
agreement
result
report
rodger
espejo
et
al
kalica
et
al
socal
mtype
emc
viru
capabl
induc
diabet
mellitu
mice
select
b
cell
damag
memc
strain
use
laboratori
partial
lost
capac
attempt
reisol
diabetogen
variant
elucid
caus
chang
seven
serial
heart
passag
mice
enrich
variant
clone
viru
stock
yield
one
clone
diabetogen
two
ten
anim
clone
test
far
differ
substrain
mecm
viru
highli
diabetogen
dvariant
obtain
dr
petersen
found
diabetogen
nondiabetogen
clone
incid
sever
diabet
shown
agerel
safeti
studi
demonstr
whether
granulosi
viru
gv
laspeyresia
pomonella
rep
licat
vertebr
feed
gv
nmrimic
viru
induc
antibodi
could
detect
within
eighti
day
radioimmunoassay
ria
vertic
viru
transmiss
observ
gv
replic
mice
human
sera
well
sera
hors
cattl
sheep
swine
react
gv
ria
character
posit
react
human
immunoglobulin
es
igg
show
strongest
posit
reaction
less
posit
reaction
shown
ige
igm
reaction
iga
igd
concentr
immunoglobulin
neg
react
sera
pg
iggml
sera
could
recogn
posit
thu
nonimmunolog
reaction
suggest
infect
human
fibroblast
cytomegaloviru
induc
typic
cytopath
alter
cell
round
within
h
postinfect
pi
follow
increas
cell
size
appear
cytoplasm
nuclear
inclus
morpholog
chang
epitheloid
cell
shape
h
pi
order
elucid
particip
cytoskeleton
alter
cell
morpholog
experi
initi
serumstarv
human
fibroblast
visual
chang
actin
arrang
indirect
immunofluoresc
earli
h
pi
cytoplasm
microfilamenr
shorten
rearrang
irregular
pattern
h
pi
actin
fiber
absent
round
cell
observ
epitheloid
cell
h
pi
cultiv
infect
cell
phosphonoacet
acid
result
partial
preserv
normal
actin
fiber
distribut
contrast
infect
cell
exhibit
major
chang
actin
synthesi
estim
specif
radioact
cytoplasm
actin
isol
puls
label
infect
cell
dnaas
isepharos
affin
chromatographi
sdspolyacrylamid
electrophoresi
fluorographi
chicken
erythrocyt
coat
glycineextract
cmv
antigen
neg
control
antigen
treatment
formaldehyd
crcl
use
detect
cmv
specif
serum
antibodi
pha
test
sensit
proven
good
agreement
specif
superior
result
seen
cft
igmspecif
cmv
antibodi
detect
perform
either
simpl
rapid
deaecellulos
exchang
chromatographi
serum
sampl
igg
immunoprecipit
combin
mereduct
control
main
advantag
modifi
cmvphat
seen
stabil
sensit
erythrocyt
lyophil
lanver
merten
th
egger
h
j
report
herp
simplex
viru
hsv
could
isol
genitourinari
tract
ofo
male
without
manifest
herp
order
confirm
result
first
want
establish
method
type
possibl
hsv
isol
use
publish
method
plaqu
test
chick
embryo
cell
neutralis
test
analysi
earli
hsvprotein
sdspage
method
yield
ident
result
tri
isol
hsv
materi
asymptomat
male
urethr
swab
semin
fluid
fresh
tissu
probe
materi
immedi
inocul
tube
cultur
two
cell
line
shown
highli
hsvsuscept
addit
tissu
probe
cocultiv
permiss
cell
also
induc
cell
fusion
peg
cocultur
despit
effort
isol
viru
materi
experiment
approach
answer
question
viral
gene
may
control
pathogenesi
peripher
infect
inbr
mice
hsv
isol
variant
strain
angpath
prove
highli
neuropathogen
upon
ip
intravagin
infect
apathogen
strain
ang
two
alter
ang
genom
detect
restrict
enzym
analysi
loss
amplifi
bp
nucleotid
sequenc
typic
ang
bp
delet
approxim
posit
map
structur
viral
glycoprotein
despit
induct
interferon
nkcell
variant
multipli
similar
extent
probabl
target
cell
peritoneum
spread
peritoneum
spleen
liver
thymu
local
lymph
node
en
seem
howev
control
action
gene
product
code
one
variant
div
expo
virolog
insr
med
microbiolog
univ
mainz
knoblich
friedrich
goertz
falk
herpesvirus
known
caus
infect
men
anim
strong
differ
resist
herp
simplex
viru
note
among
mice
variou
strain
antihsvact
tiymphocyt
macrophag
nk
cell
demonstr
last
year
interest
focus
neutral
antibodi
primari
abstract
th
meet
oghm
infect
mice
antibodi
becom
detect
day
infect
reach
plateau
level
day
day
chose
test
sera
comparison
antibodi
titer
strain
mice
reveal
titer
alway
higher
femal
mice
wherea
clear
influenc
either
background
genom
could
detect
sexual
steroid
produc
ovari
test
identifi
exert
influenc
antibodi
format
castrat
experi
treatment
mice
silica
day
day
infect
result
strong
increas
antibodi
titer
femal
male
time
abolish
differ
antibodi
titer
sex
silica
could
enhanc
antibodi
level
also
immunis
mice
formolinactiv
hsvvaccin
bestatin
small
peptid
knownselect
stimul
dna
metabol
tlymphocyt
enhanc
hsvantibodi
titer
maxim
given
day
infect
pretreat
mice
silica
antibodi
augment
effect
alreadi
achiev
day
infect
secondari
hsvl
infect
bestatin
act
best
day
infect
insr
f
med
virologi
univ
heidelberg
induct
character
herp
simplex
viru
reisol
isol
intertyp
superinfect
latent
infect
tupaia
darai
g
scholz
j
suscept
juvenil
adult
tupaia
herp
simplex
viru
type
report
intertyp
recombin
herp
simplex
viru
use
temperaturesensit
mutant
hsvl
superinfect
wildtyp
hsvl
studi
found
anim
surviv
infect
x
x
l
pfu
rs
mutant
hsvl
inocul
intraven
hsvl
inocul
anim
protect
superinfect
hsvl
x
pfuanim
state
viral
latenc
surviv
anim
investig
found
infecti
viru
recov
ganglia
anim
initi
infect
wildtyp
hsvl
superinfect
wildtyp
virus
contrast
infecti
virus
recov
spleen
anim
initi
infect
ts
mutant
hsvl
superinfect
wildtyp
found
recov
virus
spleen
anim
lost
pathogen
natur
tissu
tropism
signific
chang
genom
recov
virus
spleen
detect
recombin
ts
mutant
hsvl
challeng
wildtyp
virus
observ
thu
pathogen
genom
properti
recov
virus
alter
observ
first
descript
gener
inrerryp
recombin
hsvl
vivo
oiv
expo
virolog
inst
med
microbiolog
univ
mainz
function
hsvcode
dpykcomplex
enzym
labenz
j
brauer
moller
w
e
g
falk
analys
phosphoryl
capac
hsvcode
dpyk
hsvl
glycerol
gradient
centrifug
detect
three
peak
differ
molecular
weight
use
atp
aop
amp
phosphat
donor
also
page
peak
differ
rjvalu
could
seen
inde
use
phosphoryl
dthd
ampdepend
activiri
could
purifi
boofold
two
antisera
hsvcode
pdyk
neutral
three
activ
tkmutant
mdk
induc
ikr
cell
respect
activ
cellular
tk
detect
identifi
rjvalu
experi
shown
hsvldpyk
thymidyl
kinas
activ
hsvl
thymidyl
kinas
activ
could
neutral
tkantiserum
phoptimum
sensit
mg
fe
zn
co
mri
ion
differ
suscept
thiol
reagent
differ
ampdepend
activ
prove
suscept
phenanthrolin
also
k
vrnaxvalu
detect
diagram
summar
biochem
function
hsvcode
dpykcomplex
final
indic
enzym
phosphoryl
ado
use
dtmp
atp
phosphat
donor
import
enzym
complex
hsvinfect
cell
discuss
dkfz
inst
f
virusforschung
neuenheim
feld
delet
n
clone
fragment
propag
rec
e
coli
hb
gray
c
p
jellinghau
u
kaerner
h
c
passag
hsv
high
mol
result
gener
defect
genom
full
length
consist
rel
short
region
wild
type
genom
repeat
packag
matur
viru
particl
thu
leav
cell
state
capabl
enter
new
host
defect
molecul
interest
repres
simpler
model
studi
replic
recombin
packag
hsv
defect
molecul
aris
serial
passag
hsvtype
lang
map
restrict
fragment
clone
pbr
use
rec
aecoh
hb
host
result
clone
found
unstabl
contain
delet
one
characteris
detail
isol
character
tupaia
herpesvirus
thi
report
analysi
dna
virus
show
absenc
submolar
dna
fragment
dna
cleav
differ
restrict
enzym
well
stem
loop
structur
analys
electron
microscopi
respect
genom
structur
interest
studi
recombin
event
thv
recombin
gener
virus
use
coinfect
techniqu
vitro
tupaia
fibroblast
recombin
select
stock
new
progenc
viru
treat
specif
antiserum
parent
viru
differ
recombin
isol
plaquepurifi
character
result
one
recombin
follow
vitro
host
rang
vivo
pathogen
juvenil
tupaia
alter
compar
parent
virus
phosphoryl
protein
posttransl
modif
regulatori
activ
sever
enzym
anim
virus
code
phosphoprorein
degre
phosphoryl
thought
control
factor
viral
macromolecular
synthesi
recent
studi
protein
kinas
number
tumor
virus
rais
possibl
phosphoryl
cell
protein
involv
process
lead
cell
transform
incub
purifi
tree
shrew
tupaia
herpesviru
thv
particl
atp
result
incorpor
label
phosphat
protein
nonion
deterg
necessari
detect
protein
kinas
activ
incorpor
proport
quantiti
th
viral
protein
indic
viral
protein
serv
substrat
viral
enzym
datp
atp
function
phosphat
donor
dival
cation
mn
essenti
enzymat
activ
product
analysi
reveal
six
viral
polypeptid
phosphoryl
predomin
site
phosphoryl
foh
group
serin
threonin
herpesviru
isol
young
goat
sever
gener
infect
california
isol
character
detail
name
caprin
herpesviru
recent
herpesviru
isol
switzerland
goat
similar
infect
report
character
isol
propos
classif
bovid
herpesviru
multipli
rapidli
show
broad
hostcel
rang
crossneutr
onl
could
observ
ibripvviru
one
way
reaction
gel
immunoelectrophoresi
serolog
relationship
envolv
major
antigen
compon
evalu
two
method
analysi
antibodi
direct
ebvspecifi
protein
indirect
immunoprecipit
ip
radioimmunoassay
electroblot
sd
page
separ
ebvspecifi
protein
riab
use
ip
identifi
protein
antibodi
made
infect
protein
also
found
use
latter
techniqu
mani
protein
reactiv
eavca
sera
ractiv
eavca
sera
may
therefor
candid
ea
specifi
protein
seem
like
failur
identifi
protein
use
riab
techniqu
probabl
due
strong
denatur
condit
use
sd
page
step
antibodi
direct
toward
primari
sequenc
protein
react
blot
protein
wherea
ip
analysi
nativ
protein
avail
interact
sera
previousl
demonstr
synthesi
ebvinduc
protein
superinfect
raji
cell
raji
could
divid
phase
primari
secondari
tertiari
bayliss
wolf
j
gen
virol
press
recent
experi
show
incub
raji
si
presenc
canavanin
absenc
arginin
allow
limit
express
viral
genom
cell
releas
canavanin
block
appli
h
post
infect
h
later
sever
new
protein
synthes
howev
mrna
synthesi
inhibit
actinomycin
remov
canavanin
new
protein
fail
appear
amongst
protein
member
ebvspecifi
earli
antigen
complex
ea
result
indic
argininecontain
protein
synthes
soon
infect
protein
requir
activ
form
order
synthes
mrna
secondari
group
protein
amongst
protein
major
compon
earli
antigen
ea
complex
max
von
pettenkof
inst
univ
miinchen
entklinik
univ
wiirzburg
dept
tumor
virolog
chines
acad
med
sci
beij
china
seibl
r
richter
w
zeng
gu
sy
wolf
h
antibodi
titer
iga
antiviru
capsid
antigen
vca
use
screen
earli
tumor
case
confirm
histolog
diagnos
longtim
surveil
therapi
howev
high
risk
area
china
incid
npc
popul
iga
anti
vca
antibodi
indic
need
method
allow
monitor
addit
paramet
decid
need
therapi
need
exist
case
long
term
year
survivor
npc
constant
iga
anti
vca
titer
develop
system
collect
cell
specimen
applic
buffer
tumor
site
collect
cell
directli
nitrocellulos
filter
cell
examin
cytolog
ebv
dna
nucleic
acid
hybrid
latter
test
modif
grunstein
hog
coloni
hybrid
test
clone
ebv
dna
use
reconstruct
experi
virusproduc
cell
could
detect
inst
f
klin
virologi
univ
erlangenniimberg
keil
g
fleckenstein
b
infect
permiss
cell
cultur
overlap
restrictionfrag
viral
dna
deriv
differ
strain
herpesviru
saimiri
h
saimiri
number
recombin
could
isol
analysi
viral
protein
wtstrain
omi
led
identif
four
protein
differ
within
strain
respect
molecular
weight
abl
local
protein
intern
region
mdna
compar
protein
pattern
recombin
parent
strain
exact
local
far
possibl
recombin
event
occur
mainli
region
near
end
ldna
furthermor
recombin
construct
identifi
genom
region
respons
oncogen
wtstrain
h
saimiri
oncogen
attenu
strain
obtain
strain
lost
properti
may
due
delet
md
left
end
ldna
recombin
attenu
strain
wtstrain
construct
test
oncogen
vivo
progress
tiymphoid
cell
contain
genom
copi
per
cell
episom
begun
studi
translat
transcript
transform
cell
comparison
lytic
infect
omkcel
new
protein
detect
lyric
infect
cell
appar
molecular
weight
kd
earli
late
stage
infect
right
part
genom
preferenti
transcrib
dnafrag
encod
seri
specif
rna
contrast
find
virusspecif
protein
transform
cell
label
subsequ
immunoprecipit
preliminari
result
may
suggest
virusspecif
rna
found
transform
cell
small
rna
molecular
weight
kb
detail
analysi
perform
order
confirm
hybrid
data
max
von
pettenkof
inst
miinchen
character
herpesviru
saimiri
glycoprotein
modrow
wolf
h
identif
herpesviru
saimiri
glycoprotein
seper
h
saimiri
induc
cell
protein
sdspolyacrylamid
gel
transfer
polypeptid
electrophoret
blot
h
macm
nitrocellulos
paper
use
carbon
electrod
buffer
soak
spong
cover
gelfilt
layer
lectin
known
bind
specif
certain
sugar
residu
concanavalin
dglucos
dmannos
deriv
soy
bean
agglutinin
nacetyldgalactosamin
dgalactos
dolicho
bifloru
agglutinin
nacetyldgalactosamin
ulex
europaeu
agglutinin
lfucos
iodin
use
neniactoperoxidas
system
glycoprotein
bound
nitrocellulos
sheet
detect
incub
lectin
eight
viral
glycoprotein
could
identifi
two
synthes
presenc
canavanin
character
accord
type
glycosyl
lymphocysti
diseas
ld
viru
diseas
marin
fish
almost
worldwid
geograph
distribut
diseas
characteris
papillomalik
tumour
lesion
lymphocysti
diseas
viru
fdlv
tent
classifi
belong
famili
iridovirida
report
describ
anatomi
fdlv
fdlv
virion
isol
total
fish
ld
lesion
caught
near
doggerbank
includ
flounder
dab
plaic
analys
individu
puriti
viru
prepar
examin
negativestain
techniqu
virion
diamet
determin
flounder
nm
ldvplaic
nm
ldvdab
nm
dna
differ
ldv
isol
cleav
differ
restrict
endonucleas
result
dna
fragment
separ
electrophoret
agaros
slab
gel
fragment
pattern
demonstr
ldv
dna
flonder
plaic
indistinguish
clearli
differ
dab
determin
molecular
weight
fdlv
dna
use
contour
length
measur
electron
microscopi
result
valu
rang
x
dalton
contrast
molecular
weight
estim
restrict
enzym
analysi
result
lower
valu
rang
x
dalton
discrep
probabl
due
restrict
permut
structur
ldv
genom
similar
genom
frog
viru
report
granoff
structur
fldv
constitu
interact
host
cell
remain
obscur
effort
clarifi
viral
compon
function
studi
protein
purifi
fldv
search
virionassoci
enzym
least
distinct
viral
polypeptid
detect
polyacrylamid
gel
electrophoresi
denatur
condit
polypeptid
pattern
remark
specif
given
fish
speci
flounder
plaic
dab
although
heterogen
found
protein
individu
fish
speci
analys
found
nucleosid
triphosph
phosphohydrolas
activ
close
associ
fldv
particl
activ
hydrolys
atp
high
prefer
reaction
requir
nonion
deterg
dival
cation
reaction
rate
substrat
specif
determin
product
reaction
nucleosid
disphophar
inorgan
phosphat
character
poxviru
isol
white
rhinocero
ceratotherium
simum
pilaski
schaller
k
olberd
p
fink
hannelor
septemb
outbreak
poxdiseas
occur
white
rhinoceros
ceratotherium
simum
munster
zoo
time
similar
outbreak
observ
eleph
elepha
maximu
loxodonta
africana
zoo
frankfurt
airlin
distanc
km
case
orthopoxviru
strain
could
isol
similar
ident
biolog
properti
small
effloresc
cam
hemorrhag
center
inclus
bodi
type
v
high
pathogen
rabbit
skin
characterist
skin
lesion
adult
mice
dna
restrict
pattern
xho
eco
r
hin
iii
viru
strain
incorpor
group
cowpoxlik
virus
baxbi
ghaboosi
result
indic
outbreak
occur
independ
character
protein
specif
associ
releas
extracellular
vaccinia
particl
hiller
g
aulbach
h
infecti
vaccinia
viru
isol
infect
cell
experiment
induc
lysi
intracellular
viru
growth
medium
infect
cultur
extracellular
viru
character
protein
present
extracellular
particl
amino
acid
composit
behaviour
isoelectr
focus
addit
use
antiserum
detect
distribut
within
infect
cell
protein
late
viral
protein
appear
h
pi
predominantli
found
associ
cellular
golgi
complex
never
structur
repres
pox
viru
factori
later
infect
protein
incorpor
singl
viral
particl
preferenti
found
cell
peripheri
upon
electron
microscopi
approxim
morpholog
matur
virion
insid
cell
enwrap
doublemembran
vesicular
structur
thu
viral
protein
probabl
compon
vesicular
structur
vesicul
virion
releas
cell
lysi
occur
epidemiolog
influenza
lower
saxoni
willer
h
hopken
w
influenza
surveil
lower
saxoni
mainli
base
laboratori
investig
especi
attempt
isol
influenza
virus
throughout
year
winter
winter
two
influenza
subtyp
hini
circul
time
subtyp
affect
last
year
person
agegroup
wherea
hini
subtyp
affect
person
younger
year
winter
influenza
b
found
epidemiolog
extent
diseas
caus
outbreak
mostli
school
kindergarten
also
affect
adult
midjanuari
midfebruari
scatter
outbreak
caus
subtyp
hinl
particularli
affect
schoolchildren
contrarili
hini
subtyp
mostli
infect
young
adult
influenza
subtyp
circul
januari
march
inst
f
med
mikrobiologi
abr
virologi
tu
biederstein
str
antibodi
influenza
c
viru
popul
germani
kenia
australia
pfeilputzien
c
meierewert
h
one
hundr
human
sera
three
countri
germani
kenia
australia
test
antibodi
influenza
c
viru
use
convent
hemagglutin
inhibit
test
hi
rate
posit
sera
show
hi
titer
amount
ofo
germani
ofo
kenia
ofo
australia
age
group
year
ofo
german
ofo
kenian
sera
alreadi
antibodi
titer
influenza
c
viru
australian
sera
test
age
group
year
show
ofo
seroposit
result
show
influenza
c
viru
circul
higher
extend
popul
countri
subtrop
climat
compar
temper
middl
european
zone
inst
f
virologi
justusliebiguniv
giessen
proteolyt
activ
influenza
hemagglutinin
structur
cleavag
site
mechan
cleavag
garten
w
bosch
f
x
hemagglutinin
precursor
ha
posttransl
cleav
proteas
complex
h
vitro
cleavag
ha
trypsin
trysinlik
proteas
yield
infecti
viru
cleavag
thermo
lysin
chymotrypsin
yield
noninfecti
viru
analyz
cleavag
site
hi
hlo
hemagglutinin
amino
acid
sequenc
cleavag
site
e
cterminu
hal
nterminu
ha
ident
viru
activ
vivo
vitro
condit
arginin
residu
connect
hal
ha
precursor
elimin
elimin
argmm
result
shift
isoelectr
point
hemagglutinin
demonstr
isoelectr
focus
nonactiv
enzym
cleav
one
peptid
bond
ha
region
activ
ha
thu
affect
isoelectr
point
also
analyz
cleavag
site
hemagglutinin
fowl
plaqu
viru
connect
peptid
contain
sever
basic
amino
acid
elimin
data
show
activ
influenza
hemagglutinin
involv
action
cellular
proteas
trypsinlik
specif
follow
action
exopeptidas
carboxypeptidas
btype
latter
enzym
activ
associ
purifi
viru
analyz
assay
employ
peptid
bear
cterminu
carbohydr
glycoprotein
influenza
strain
contain
hemagglutinin
neuraminidas
serotyp
known
date
compar
analysi
glycopeptid
label
radioact
sugar
analysi
incomplet
glycosyl
glycoprotein
synthes
presenc
glycosyl
inhibitor
allow
determin
number
oligosaccharid
side
chain
ha
strain
neuraminidas
contain
side
chain
complex
type
mannoserich
type
ii
distinct
quantit
qualit
differ
strain
distribut
type
type
ii
side
chain
hemagglutinin
fragment
hal
ha
major
hemagglutinin
oligosaccharid
locat
hal
side
chain
usual
type
hem
agglutinin
serotyp
addit
substanti
amount
type
ii
side
chain
hal
strain
ha
singl
side
chain
usual
type
serotyp
hs
side
chain
free
fucos
serotyp
appear
miss
complet
serotyp
addit
type
type
ii
side
chain
ha
observ
strengthen
concept
primari
structur
polypeptid
chain
import
determin
carbohydr
moieti
hemagglutinin
inst
f
virologi
ustusliebiguniv
giessen
acyl
viral
glycoprotein
schmidt
f
g
coval
bind
fatti
acid
viral
glycoprotein
first
detect
sindbi
viru
vesicular
stomat
viru
studi
acyl
envelop
virus
reveal
coval
addit
fatti
acid
spike
glycoprotein
gener
featur
sindbi
semliki
forest
viru
speci
spike
glycoprotein
el
carri
fatti
acid
chain
acyl
virus
studi
corona
influenza
aand
paramyxoviru
famili
seem
restrict
glycoprotein
known
carri
fusion
activ
new
type
modif
viral
glycoprotein
occur
wide
varieti
host
cell
includ
human
bovin
mous
hamster
avian
insect
origin
aid
control
digest
acid
label
viru
particl
analysi
cyanogen
bromid
fragment
fatti
acid
label
glycoprotein
fatti
acid
bind
ing
site
influenza
hemagglutinin
hat
vsv
gprotein
sindbi
viru
could
locat
membran
span
portion
respect
protein
heinrichpetteinstitut
f
exp
virologi
u
immunologi
univ
martinistr
hamburg
mannweil
k
bohn
w
rutter
g
hohenberg
h
replicaimmunocytochem
ric
ultrathin
section
us
prepar
ultrastructur
specif
alter
viru
antigen
appear
plasma
membran
la
cell
coverslip
cultur
infect
adapt
measl
viru
strain
investig
immunomark
protein
acoat
gold
particl
use
method
suffici
sensit
enabl
label
even
small
alter
area
plasma
membran
nm
cb
due
high
atom
number
contrast
tem
small
size
marker
nm
ultrastructur
characterist
alter
morpholog
still
remain
visibl
eas
threedimension
aspect
data
obtain
ric
us
prepar
label
antimeasl
immun
serum
monoclon
antibodi
ha
demonstr
compar
discuss
bohn
w
rutter
g
mannweil
k
use
mous
hybridoma
techniqu
monoclon
antibodi
obtain
specif
ha
p
polypeptid
measl
viru
balblc
mice
immun
nativ
measl
viru
measl
viru
treat
deterg
heat
clone
obtain
immun
mice
nativ
measl
viru
show
specif
ha
polypeptid
immun
measl
viru
treat
sodium
sarkosyl
sulfat
sss
clone
obtain
produc
antibodi
polypeptid
heat
measl
viru
presenc
sd
reduc
condit
elicit
select
immun
respons
p
np
polypeptid
thu
clone
produc
antibodi
p
polypeptid
isol
contain
rna
show
infect
even
trypsin
treatment
activ
cl
viru
obtain
cocultiv
cell
standard
cell
e
g
ii
serial
passag
cl
viru
sever
cell
line
e
g
infecti
cl
viru
detect
cell
supernat
period
day
day
respect
viru
propag
chicken
egg
replic
serial
cell
cultur
without
trypsin
treatment
moreov
trypsin
treatment
influenc
viral
replicaiton
comparison
viru
releas
invitro
gener
persist
infect
cell
infect
egggrown
standard
viru
propag
chicken
egg
viru
term
pi
viru
also
grow
serial
cell
passag
without
trypsin
treatment
wherea
serial
replic
standard
viru
cell
cultur
depend
trypsinactiv
inst
f
virologi
u
immunbiologi
versbach
str
wiirzburg
monzel
p
koschel
k
paramyxvvirus
measl
sspe
viru
canin
distemp
viru
cdv
caus
impair
catecholamin
induc
padrenerg
receptor
depend
camp
gener
persist
infect
rat
glioma
cell
cdv
persist
infect
cell
number
receptor
greatli
reduc
hirata
axelrod
shown
number
iiadrenerg
receptor
could
regul
methyl
phosphatidyl
ethanolamin
pe
result
lecithin
synthesi
therefor
studi
methyl
pe
persist
infect
cell
incorpor
methyl
group
methionin
pe
infect
system
observ
total
loss
catecholamin
stimul
padrenerg
receptor
depend
methyl
wherea
preceptor
independ
methyl
phospholipid
unchang
inst
f
med
virologi
univ
heidelberg
robertkochinstitut
berlin
inst
f
virusforschung
dkfz
heidelberg
kurz
w
gelderblom
ht
flogel
r
darai
g
paramyxoviru
isol
kidney
biopsi
tupaia
three
shrew
term
tpv
detail
host
rang
studi
reveal
tupaia
embryon
fibroblast
tupaia
kidney
cell
cell
choic
effici
propag
tpv
tpv
plaqueassay
tupaia
embryon
fibroblast
cell
line
use
continu
propag
tpv
electron
microscopi
purifi
tpv
reveal
presenc
typic
paramyxoviru
particl
hemagglutin
test
perform
erythrocyt
varieti
differ
speci
found
guinea
pig
erythrocyt
agglutin
tpv
buoyant
densiti
purifi
virion
determin
sucros
gradient
found
g
x
ml
biolog
chara
cteriz
tpv
perfo
rmed
host
rang
studi
vivo
reveal
tpv
highli
pathogen
new
born
mice
hamster
character
viral
rna
protein
th
new
member
paramyxo
virida
progress
coronavirus
contain
two
glycoprotein
speci
k
k
synthes
infect
host
cell
glycosyl
initi
cotransl
level
inhibit
tunicamycin
indic
presenc
nglycosid
carbohydra
te
protein
linkag
particl
form
presen
ce
inh
ibit
or
non
infecti
lack
detect
abl
amount
cell
fraction
experi
show
glycosyl
glycoprotein
occur
posttransl
smooth
memb
rane
carb
ohydr
protein
linkag
suscept
mild
alkalin
reduct
condit
nacetylgalactosamin
determin
reduc
ing
sugar
releas
oligo
saccharid
togeth
find
glycosyl
sensit
inhibito
rs
nglycosyl
suggest
glycoprotein
coronavirus
first
structur
viru
glycoprotein
contain
oglycosid
side
chain
exclus
insr
virologi
jusrusliebiguniv
giessen
target
cell
infecti
bursal
diseas
viru
ibdv
chicken
moller
h
becht
h
infecti
bursal
diseas
viru
ibdv
caus
agent
highl
contagi
diseas
young
chicken
result
ing
sever
necrot
lesion
bur
sa
fabriciu
gumboro
diseas
nonenvelop
icosahedr
particl
diamet
nm
genom
con
sist
segment
doublestrand
rna
mol
ecular
weight
x
x
dalton
th
e
virion
compos
structur
pol
ypeptid
mole
cular
weight
kd
kd
kd
kd
kd
kd
pol
ypeptid
one
two
main
structur
protein
deriv
kd
pol
ypeptid
perh
ap
proteolyt
modif
immunofluoresc
nfectiou
center
assay
abl
show
th
infect
isol
lymphoid
cell
vitro
ofo
bur
sa
cell
thymu
cell
ofo
spleen
cell
produc
infect
viru
e
plaqu
infecti
center
assay
alth
ough
donor
chicken
suscept
age
week
number
viru
produc
cell
cor
relat
app
aranc
slgm
sigg
viru
yield
seem
influenc
cell
cycl
number
chick
emb
ryo
fibro
blast
produc
plaqu
infecti
center
assay
increas
synchro
nisa
tion
cell
infect
cell
produc
infect
viru
show
increas
uptak
isol
lymphoid
cell
thymu
spleen
well
blood
lymphocyt
stimul
mitogen
produc
higher
viru
yield
infect
borna
viru
without
influenc
immunorespons
antigen
first
appear
nucleu
neuron
sometim
fibroblast
fill
cytoplasm
brilliantli
day
post
infect
thereaft
disappear
cytoplasm
remain
persist
nucleu
point
shape
morpholog
chang
seen
infect
cell
day
post
infect
say
viru
kill
cell
destruct
nerv
cell
vivo
condit
point
import
immunolog
event
might
caus
clinic
pictur
abr
molekularbiologi
physiolchem
lnst
grindelalle
hamburg
heinrich
petteinst
martinistr
hamburg
larg
scale
product
biolog
activ
vsv
eatcel
mack
kruppa
j
breindl
mi
ehrlich
ascit
tumor
cell
maintain
mice
use
prepar
milligram
quantiti
biolog
activ
vsv
day
passag
cell
number
reach
approx
x
cellsmous
mice
infect
intraperiton
inject
appropri
concentr
vsv
ascit
fluid
harvest
h
viru
product
exponenti
least
h
continu
least
h
pi
approxim
mg
viral
proteinmous
x
pfulmous
routin
obtain
specif
infect
vsv
isol
eatcel
reach
nearli
x
pfui
ug
protein
endogen
transcriptas
activ
vsv
produc
eat
bhk
hela
cell
show
signific
differ
larg
amount
biolog
activ
vsv
may
produc
rapidli
much
less
costli
describ
procedur
use
tissu
cultur
cell
possibl
adapt
procedur
product
virus
lonza
ag
basel
schweiz
quantit
determin
formaldehyd
glyoxal
glutardialdehyd
disinfect
weinrei
p
goller
sever
institut
hygien
provid
two
disinfect
formul
b
intent
analys
mixtur
contain
differ
amount
quaternari
ammonium
compound
formaldehyd
glyoxal
glutardialdehyd
quantit
analysi
compon
two
mixtur
depend
well
known
volumetr
spectrophotometr
method
result
analysi
shown
possibl
use
describ
procedur
routin
check
up
disinfect
without
use
microbiolog
test
